Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 15, 2026 |
| Accession Number: | 0001493152-26-016154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Mergers & Acquisitions Expands Florida Leadership Team Amid Rising Demand for M&A Advisory Services
- EV Interest Climbs as Gas Price Uncertainty Pushes Families Toward Electric SUVs
- UPDATED - DREYER'S GRAND ICE CREAM, INC. ISSUES VOLUNTARY RECALL ON SELECT OUTSHINE FRUIT BARS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
